PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Cardiovascular Medicine & Sciences, King\'s College London, London, UK.\', \'Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK; Department of Diabetes, King\'s College NHS Foundation Trust, London, UK; King\'s Health Partners\' Institute of Diabetes, Endocrinology and Obesity, London, UK.\', \'School of Cardiovascular Medicine & Sciences, King\'s College London, London, UK; King\'s Health Partners\' Institute of Diabetes, Endocrinology and Obesity, London, UK.\', \'Department of Diabetes, King\'s College NHS Foundation Trust, London, UK; King\'s Health Partners\' Institute of Diabetes, Endocrinology and Obesity, London, UK. Electronic address: prashanth.vas@nhs.net.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0026-2862(21)00180-110.1016/j.mvr.2021.104310
?:hasPublicationType
?:journal
  • Microvascular research
is ?:pmid of
?:pmid
?:pmid
  • 34979154
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.974
?:rankingScore_hIndex
  • 81
is ?:relation_isRelatedTo_publication of
?:title
  • What is the impact of microvascular complications of diabetes on severe COVID-19?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all